Teladoc Health (TDOC) Earnings Analysis
Teladoc Health (TDOC) next reports earnings on 2026-07-29, consensus EPS -0.24 USD. Last quarter (2026-02-25) it beat with EPS -0.14 USD vs -0.19 USD est (+26.3%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -9.20.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TDOC next report earnings?
| Next earnings date | 2026-07-29 |
|---|---|
| Consensus EPS estimate | -0.24 USD |
| Revenue estimate | 0.61B |
TDOC earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-25 | -0.14 USD | -0.19 USD | +26.3% | Beat |
| 2025-04-30 | -0.19 USD | -0.33 USD | +42.4% | Beat |
| 2025-02-26 | -0.28 USD | -0.21 USD | -33.3% | Miss |
| 2024-07-31 | -0.28 USD | -0.36 USD | +22.2% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
TDOC valuation and analyst view
| Trailing P/E | -9.20 |
|---|---|
| Trailing EPS | -0.95548 USD |
| Price / book | 1.20 |
| Dividend yield | 0.00% |
| Market cap | 1.62B |
| Analyst consensus | Hold (15 buy / 27 hold / 0 sell) |
| Avg price target | 11 USD |
Related research pages
Frequently asked questions
When is Teladoc Health (TDOC)'s next earnings date?
Teladoc Health is next scheduled to report on 2026-07-29, with a consensus EPS estimate of -0.24 USD and revenue estimate of 0.61B.
Did TDOC beat earnings last quarter?
In its 2026-02-25 report, TDOC posted EPS of -0.14 USD versus a -0.19 USD estimate — a beat of 26.3%.
What is TDOC's earnings track record?
Over the last 4 reported quarters with consensus data, TDOC beat estimates 3 times (75%).
What is TDOC's current P/E ratio and EPS?
TDOC trades at a trailing P/E of -9.20 on trailing EPS of -0.9554758429030163 USD.
What do analysts rate TDOC?
Analyst consensus is "Hold" across 42 ratings (0 strong buy, 15 buy, 27 hold, 0 sell, 0 strong sell). Average 12-month price target: 11 USD.